A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Children With Gaucher Disease Under 5 Years Old

Condition:   Gaucher Disease Intervention:   Other: Standard of Care Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials